No Data
Dajiah VICOM Ltd (301126.SZ): has obtained the registration certificate for the pharmaceutical Oseltamivir phosphate granules.
According to Gronhold on January 7, Dajia VICOM Ltd (301126.SZ) announced that recently, its controlling subsidiary, Hunan Tianji Caotang Pharmaceutical Co., Ltd., received the "Drug Registration Certificate" issued by the National Medical Products Administration for Oseltamivir phosphate granules. The indications for Oseltamivir phosphate are: 1. For the treatment of influenza types A and B in patients aged 2 weeks and older (Oseltamivir phosphate can effectively treat influenza types A and B; however, clinical application data for type B influenza is still limited). Patients should use it within 48 hours of the onset of symptoms. 2. For use in 1
Dajia VICOM Ltd (301126.SZ): The application for issuing Stocks to specific targets has been accepted by the Shenzhen Stock Exchange.
On December 30, Gelonghui reported that Dajiao VICOM Ltd (301126.SZ) announced that it recently received the notice from the Shenzhen Stock Exchange regarding the acceptance of the application documents for the issuance of stocks to specific targets by Hunan Dajiao VICOM Ltd (Shenzhen Stock Exchange Review [2024] No. 319). The Exchange verified the application documents submitted by the company for the issuance of stocks to specific targets, concluded that the application documents are complete, and decided to accept it.
Dajiahui vicom ltd (301126.SZ) specific shareholder Liangji Investment and its concerted parties completed a shareholding of 1.7391 million shares.
Dajia Vicom Ltd (301126.SZ) announced that as of December 5, 2024, the specific shareholder Ningbo Meishan...
Dajia Weikang (301126.SZ) 81.8702 million shares of restricted shares will be listed and traded on December 9th.
Dajia Vicom Ltd (301126.SZ) announced that the number of shareholders whose restricted shares are released is a total of 5 households, and the restricted shares have been released...
Daga Weikang: Report for the third quarter of 2024
Vicom Ltd (301126.SZ): Its subsidiary, Jiachen Hospital, is actively promoting the application for human assisted reproduction license qualification.
Gelonghui October 11th | Dajia vicom ltd (301126.SZ) stated at an investor relations event that its subsidiary, Jiachen hospital, is actively pursuing the application for human assisted reproduction license qualification. Due to the high barriers of assisted reproduction technology, lengthy licensing application processes, and strict approval standards, there is uncertainty about the prospects of the company's continued assisted reproduction business.
Investors Still Aren't Entirely Convinced By Hunan Dajiaweikang Pharmaceutical Industry Co.,Ltd's (SZSE:301126) Revenues Despite 28% Price Jump
No Data
